Renalytix Plc (AIM:RENX)
4.078
-0.022 (-0.54%)
Aug 17, 2026, 3:49 PM GMT
Renalytix Earnings Call Transcripts
Fiscal Year 2025
-
Revenue is on track for $3.2M in FY2025 with 20% quarterly growth, driven by Medicare coverage and direct-to-doctor sales. Operational improvements have reduced costs and turnaround times, while strategic pharma collaborations and a strong US focus support future expansion.